Cargando…

Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination

Detalles Bibliográficos
Autores principales:	Fagni, Filippo, Schmidt, Katja, Bohr, Daniela, Valor-Méndez, Larissa, Hartmann, Fabian, Tascilar, Koray, Manger, Karin, Manger, Bernhard, Kleyer, Arnd, Simon, David, Schett, Georg, Harrer, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121106/ https://www.ncbi.nlm.nih.gov/pubmed/35589333 http://dx.doi.org/10.1136/rmdopen-2022-002323

Ejemplares similares

Hepatitis-E-Virus-Infektion bei einem Patienten mit rheumatoider Arthritis unter Baricitinib-Therapie
por: Valor-Méndez, Larissa, et al.
Publicado: (2021)

Massive nodulous lesions on hands and feet in a RA patient and improvement under baricitinib treatment
por: Valor-Méndez, Larissa, et al.
Publicado: (2020)

Sustained clinical remission under infliximab/rituximab combination therapy in a patient with granulomatosis with polyangiitis
por: Valor-Méndez, Larissa, et al.
Publicado: (2021)

Lymph node and pulmonary tuberculosis during upadacitinib treatment in a psoriatic arthritis patient
por: Valor-Méndez, Larissa, et al.
Publicado: (2022)

Re-exposure with a TNF inhibitor bio-similar was well tolerated and led to sustained control of psoriatic arthritis after allergic reaction to the TNF inhibitor bio-originator
por: Valor-Méndez, Larissa, et al.
Publicado: (2022)

Humoral and Cellular Immune Responses to SARS–CoV‐2 Infection and Vaccination in Autoimmune Disease Patients With B Cell Depletion
por: Simon, David, et al.
Publicado: (2021)

Clinical Images: Tissue remodeling in autoimmune statin‐induced necrotizing autoimmune myopathy
por: Valor‐Méndez, Larissa, et al.
Publicado: (2022)

Performance of a Handheld Ultrasound Device to Assess Articular and Periarticular Pathologies in Patients with Inflammatory Arthritis
por: Corte, Giulia, et al.
Publicado: (2021)

Casirivimab/Imdevimab: First Approval
por: Deeks, Emma D.
Publicado: (2021)

Casirivimab and imdevimab for COVID-19
Publicado: (2022)

Casirivimab/imdevimab: Lack of efficacy: case report
Publicado: (2022)

Use of Casirivimab and Imdevimab for the Treatment of COVID-19
por: Liu, Ryan, et al.
Publicado: (2022)

Casirivimab - Imdevimab in Covid 19 – Early Indian experience
por: Venkitakrishnan, Rajesh, et al.
Publicado: (2022)

Casirivimab/imdevimab: Various toxicities: 2 case reports
Publicado: (2022)

Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
por: Somersan-Karakaya, Selin, et al.
Publicado: (2022)

Biomechanical stress in the context of competitive sports training triggers enthesitis
por: Simon, David, et al.
Publicado: (2021)

Cinematic rendering in rheumatic diseases—Photorealistic depiction of pathologies improves disease understanding for patients
por: Pachowsky, Milena L., et al.
Publicado: (2022)

Treatment of COVID-19 with monoclonal antibodies casirivimab and imdevimab in pregnancy
por: Folkman, Rebecca, et al.
Publicado: (2022)

Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19
por: Jalbert, Jessica J., et al.
Publicado: (2022)

Efficacy and drug persistence of baricitinib monotherapy is similar to combination therapy in patients with active RA: a prospective observational study
por: Bayat, Sara, et al.
Publicado: (2022)

Digital Approaches for a Reliable Early Diagnosis of Psoriatic Arthritis
por: Fagni, Filippo, et al.
Publicado: (2021)

Casirivimab/imdevimab lack of efficacy against COVID-19 Omicron variant
Publicado: (2022)

PROLONGED COVID-19 INFECTION IN AN IMMUNOSUPPRESSED PATIENT TREATED WITH CASIRIVIMAB/IMDEVIMAB
por: TOOR, SUBHAN A, et al.
Publicado: (2022)

Annular lichenoid eruption following treatment with casirivimab/imdevimab for COVID-19
por: Markovitz, Netana H., et al.
Publicado: (2022)

Similar Impact of Psoriatic Arthritis and Rheumatoid Arthritis on Objective and Subjective Parameters of Hand Function
por: Liphardt, Anna‐Maria, et al.
Publicado: (2020)

Neutralizing monoclonal antibodies against SARS-CoV-2 for COVID-19 pneumonia in a rituximab treated patient with systemic sclerosis—A case report and literature review
por: Yalcin Mutlu, Melek, et al.
Publicado: (2022)

Combination Therapy With Casirivimab/Imdevimab and Remdesivir for Protracted SARS-CoV-2 Infection in B-cell-Depleted Patients
por: Dioverti, M Veronica, et al.
Publicado: (2022)

Clinical Prognosis of Patients With Mild COVID-19 Treated With Casirivimab/Imdevimab in Japan
por: Osugi, Yasuhiro, et al.
Publicado: (2022)

Dégradation respiratoire post Casirivimab/Imdevimab : fréquence et facteurs de risque
por: Gerber, V., et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome in an Adult Who Received Casirivimab-Imdevimab (REGEN-COV)
por: Singh, Gurdeep, et al.
Publicado: (2022)

A SEVERE ADVERSE DRUG REACTION (ADR) TO REGEN-COV (CASIRIVIMAB AND IMDEVIMAB)
por: Abou-Jaoude, E., et al.
Publicado: (2022)

Autoinflammation leading to autoimmunity in adult-onset Still’s disease: more than simple coincidence?
por: Valor-Méndez, Larissa, et al.
Publicado: (2021)

SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseases
por: Simon, David, et al.
Publicado: (2021)

Advanced machine learning for predicting individual risk of flares in rheumatoid arthritis patients tapering biologic drugs
por: Vodencarevic, Asmir, et al.
Publicado: (2021)

Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia
por: Phan, Alexander T, et al.
Publicado: (2021)

506. Outpatient Bamlanivimab, Casirivimab and Imdevimab for COVID-19: Single Center Feasibility Analysis
por: Chundi, Vahini, et al.
Publicado: (2021)

1144. Rate of Infusion Reactions Among Patients Receiving Casirivimab/Imdevimab in the Home Setting
por: Simpson, Michelle, et al.
Publicado: (2022)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Impact of Cytokine Inhibitor Therapy on the Prevalence, Seroconversion Rate, and Longevity of the Humoral Immune Response Against SARS–CoV‐2 in an Unvaccinated Cohort
por: Simon, David, et al.
Publicado: (2022)

Misdiagnosis of polymyositis in a young female patient with occult limb-girdle muscular dystrophy
por: Valor-Méndez, Lara, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mi2l1bghjuk1npeo96asgcudkb